
News|Articles|November 26, 2012
FDA approves first cell-culture vaccine for seasonal influenza
FDA approved Influenza Virus Vaccine (Flucelvax, Novartis Vaccines, the first cell-culture-derived vaccine, for individuals aged 18 years of age and older
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement























